The Coalition to Reduce Spending was proud to join a group of over 15 diverse organizations urging strong support for reforming the Department of Veterans Affairs (VA) medical system.
This letter urged Congress to focus on VA reform that would increase choices for veterans, protect the nation’s taxpayers, and increase transparency of costs and quality of care.
Caring for our veterans and reducing the burden for taxpayers are important issues that we are proud to support. You can read the full letter here.
The Military Times also highlighted the coalition letter, which you can read here.
Note: This post originally ran at the Institute to Reduce Spending.
This week, the House and Senate have been crafting their drafts of a 2018 budget resolution, but the two chambers still have a ways to go in order to reach an agreement.
The House budget seeks to cut Medicare and Medicaid by $473 billion and $1 trillion over the next decade, respectively. In addition, it would find savings from entitlement programs such as food stamps and student loan programs.
The Senate’s plan would keep defense spending flat over the next 10 years, while cutting $5.1 trillion in domestic spending.
Senator Bob Corker (R-TN) expressed his discontent with what seems to be a Senate budget that will add $1.5 trillion to the deficit, saying that the debt, “is the greatest threat to our nation.”
Congress will have to iron out the details by their December 9th deadline to pass the budget resolution. The 52 Republicans in the Senate will require support from Democrats in order to reach the 60 vote threshold to send the legislation to the President’s desk.
Today, the Coalition to Reduce Spending was proud to join a bipartisan group of organizations urging Congressional leadership take action on the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
This legislation would encourage competition in the drug industry, lowering prescription prices for both consumers and the government.
We’re proud to add our name alongside over 35 diverse stakeholders and push for meaningful healthcare reform.
Read the full letter here.
On Friday, the U.S. officially surpassed $20 trillion in debt. This milestone marks an inevitable but deeply disappointing moment for fiscal conservatives of all kinds.
This historic moment in our nation’s history further signals the need for spending reforms and fiscal responsibility across the federal government.
There is no better time than now to demand to our elected officials that dealing with our runaway debt and spending should be at the forefront of all policy discussions.
If I told you Republican Senators Mike Lee (R-UT) and John McCain (R-AZ), came together with Democratic Senators Diane Feinstein (D-CA) and Patrick Leahy (D-VT)—among others—to sponsor a bill, would you believe it?
The Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (or CREATES Act) brings Senators from across the political spectrum together. The bill has the potential to bring down prices for government and consumers by encouraging competition in the drug market.
Under FDA regulations, drug companies are legally required to provide samples to FDA-approved generic companies when requested once a drug patent expires so that generics can prove their safety. FDA regulations also require that manufacturers participate in Risk Evaluation and Mitigation Strategies—or REMS—when dealing with dangerous and possibly fatal drugs, but brand-name manufacturers often refuse to share samples or let competitors participate in shared safety protocols.
With CREATES, generic manufacturers have a path to relief if companies refuse to sell samples of the drugs or participate in REMS.
Now, we’re hearing that the bill may be used as a pay-for to reauthorize the Children’s Health Insurance Program (CHIP) at the end of the month. While full details and potential savings are not yet known, this is an encouraging opportunity to see much-needed reforms that both sides can support, at a time when Congress seems to butt heads on nearly every other issue.